Microarray Analysis Reveals Overexpression of both Integral Membrane and Cytosolic Tight Junction Genes in

Maria E Cuevas1, Chance P Winters1, Maria C Todd1

  • 1Biology Department, Southwestern University, Georgetown, TX 78626.

Journal of Cancer
|December 9, 2022
PubMed

Insights

Tight junction (TJ) protein deregulation is implicated in endometrial cancer. This study found overexpression of claudin-3, claudin-4, occludin, JAM-A, and ZO-3 genes in endometrial cancer cell lines, suggesting a role in disease development.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Deregulation of tight junction (TJ) proteins disrupts TJ function, contributing to endometrial cancer development.
  • Understanding the specific TJ proteins involved is crucial for comprehending endometrial cancer pathogenesis.

Purpose of the Study:

  • To investigate the expression of TJ and TJ-associated genes in human endometrial cancer cell lines.
  • To identify specific TJ proteins that are overexpressed and may play a role in endometrial cancer.

Main Methods:

  • Reverse transcription-polymerase chain reaction (RT-PCR) to detect claudin-3 and -4 mRNA.
  • Immunoblotting to confirm claudin-3 and -4 protein overexpression.
  • Microarray analysis of 84 TJ and TJ-associated genes in 9 endometrial cancer cell lines.

Main Results:

  • Overexpression of claudin-3 and claudin-4 mRNA and protein confirmed in endometrial cancer cell lines.
  • Microarray analysis revealed overexpression of claudin-3 and claudin-4 genes.
  • Additional overexpression of OCLN (occludin), F11R (JAM-A), and TJP3 (ZO-3) genes observed in 8 out of 9 cell lines.

Conclusions:

  • Structural disruption of TJs, indicated by the overexpression of specific TJ proteins like claudins, occludin, JAM-A, and ZO-3, may contribute to endometrial cancer.
  • Deregulation of TJ-associated signaling pathways involved in proliferation and migration likely plays a role in endometrial cancer development.